Abstract: Provided are an obstacle detection method and apparatus, a device and a storage medium. The obstacle detection method may include: determining a detection planar region according to a mobile robot and a target position, wherein a distance from a point in the detection planar region to a connecting line between the mobile robot and the target position does not exceed a detection fixed value; determining a shortest distance from an obstacle to the connecting line between the mobile robot and the target position based on a vector distance method; and determining whether the obstacle is present in the detection planar region according to a result of comparison of the shortest distance with the detection fixed value.

Abstract: A testing fixture includes a base, a signal source, a workstation and a crimping mechanism. The base is provided with a sloping surface carrying the workstation and the crimping mechanism. The signal source is located on the base. The crimping mechanism applies testing signals transmitted by the signal source to the product to be tested. Additionally, the workstation performs an electrical function test on the product to be tested. The testing fixture can effectively perform an electrical function test on the product to be tested and has an integrated design of the base, the signal source, the workstation and the crimping mechanism, which facilitates management and maintenance. The base is also provided with a sloping surface carrying the workstation and the crimping mechanism to provide the testing fixture with an optimal testing angle, thereby facilitating operation and production.

Abstract: A testing fixture comprising a base, a signal source, a workstation and a crimping mechanism, the base is provided with a sloping surface carrying the workstation and the crimping mechanism, the signal source is located on the base, the crimping mechanism applies testing signals transmitted by the signal source to the product to be tested, and the workstation performs a light-on test on the product to be tested.

Abstract: The present invention provides a method for recording programs, a multimedia system and a network side device. The multimedia system includes a network side device and a plurality of nodes, wherein the network side device is configured to generate a recording task after receiving a recording request, and send in advance the recording task to each node in which a channel specified in the recording task is stored, and the nodes are configured to record a program on the channel specified in the recording task after receiving the recording task, and return recording result information to the network side device. According to the recording method of the present invention, when the recording is failed, inter-node mutual reconstruction and complementary recording can be performed, which greatly decreases the possibility of failure in the recording of the program, and provides the quality of service of more fluent TVOD for users.

Abstract: The invention provides novel mutations, mutation combinations or mutational profiles of HIV-1 reverse transcriptase and/or protease genes correlated with phenotypic resistance to HIV drugs. More particularly, the present invention relates to the use of genotypic characterization of a target population of HIV and the subsequent correlation of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention also relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design, clinical management and diagnostic analysis.

Abstract: The present invention provides a method for recording programs, a multimedia system and a network side device. The multimedia system includes a network side device and a plurality of nodes, wherein the network side device is configured to generate a recording task after receiving a recording request, and send in advance the recording task to each node in which a channel specified in the recording task is stored, and the nodes are configured to record a program on the channel specified in the recording task after receiving the recording task, and return recording result information to the network side device. According to the recording method of the present invention, when the recording is failed, inter-node mutual reconstruction and complementary recording can be performed, which greatly decreases the possibility of failure in the recording of the program, and provides the quality of service of more fluent TVOD for users.

Abstract: The invention provides novel mutations, mutation combinations or mutational profiles of HIV-1 reverse transcriptase and/or protease genes correlated with phenotypic resistance to HIV drugs. More particularly, the present invention relates to the use of genotypic characterization of a target population of HIV and the subsequent correlation of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention also relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design, clinical management and diagnostic analysis.

Abstract: A method and system for predicting the resistance of a disease to a therapeutic agent is provided. Further provided is a method and system for designing a therapeutic treatment agent for a patient afflicted with a disease. Specifically, the methods use a trained neural network to interpret genotypic information obtained from the disease. The trained neural network is trained using a database of known or determined genotypic mutations that are correlated with phenotypic therapeutic agent resistance. The present invention also provides methods and systems for predicting the probability of a patient developing a genetic disease. A trained neural network for making such predictions is also provided.

Abstract: The invention provides novel mutations, mutation combinations or mutational profiles of HIV-1 reverse transcriptase and/or protease genes correlated with phenotypic resistance to HIV drugs. More particularly, the present invention relates to the use of genotypic characterization of a target population of HIV and the subsequent correlation of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention also relates to methods of utilizing the mutational profiles of the invention in databases, drug development, i.e., drug design, and drug modification, therapy and treatment design, clinical management and diagnostic analysis.

Abstract: A method and system for predicting the resistance of a disease to a therapeutic agent is provided. Further provided is a method and system for designing a therapeutic treatment agent for a patient afflicted with a disease. Specifically, the methods use a trained neural network to interpret genotypic information obtained from the disease. The trained neural network is trained using a database of known or determined genotypic mutations that are correlated with phenotypic therapeutic agent resistance. The present invention also provides methods and systems for predicting the probability of a patient developing a genetic disease. A trained neural network for making such predictions is also provided. Also provided is a method and system for determining the genetic basis of therapeutic agent resistance.